Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).
![Thumbnail](/themes/Mirage2/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
Journal ArticleDate:
2013Access:
openAccessCitation:
Wright CM, Kirschner MB, Cheng YY, O'Byrne KJ, Gray SG, Schelch K, Hoda MA, Klebe S, McCaughan B, van Zandwijk N, Reid G, Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM)., PloS one, 8, 8, 2013, e70940Download Item:
Abstract:
Malignant Pleural Mesothelioma (MPM) is an aggressive cancer that is often diagnosed at an advanced stage and is characterized by a long latency period (20–40 years between initial exposure and diagnosis) and prior exposure to asbestos. Currently accurate diagnosis of MPM is difficult due to the lack of sensitive biomarkers and despite minor improvements in treatment, median survival rates do not exceed 12 months. Accumulating evidence suggests that aberrant expression of long non-coding RNAs (lncRNAs) play an important functional role in cancer biology. LncRNAs are a class of recently discovered non-protein coding RNAs >200 nucleotides in length with a role in regulating transcription. Here we used NCode long noncoding microarrays to identify differentially expressed lncRNAs potentially involved in MPM pathogenesis. High priority candidate lncRNAs were selected on the basis of statistical (P<0.05) and biological significance (>3-fold difference). Expression levels of 9 candidate lncRNAs were technically validated using RT-qPCR, and biologically validated in three independent test sets: (1) 57 archived MPM tissues obtained from extrapleural pneumonectomy patients, (2) 15 cryopreserved MPM and 3 benign pleura, and (3) an extended panel of 10 MPM cell lines. RT-qPCR analysis demonstrated consistent up-regulation of these lncRNAs in independent datasets. ROC curve analysis showed that two candidates were able to separate benign pleura and MPM with high sensitivity and specificity, and were associated with nodal metastases and survival following induction chemotherapy. These results suggest that lncRNAs have potential to serve as biomarkers in MPM.
Author's Homepage:
http://people.tcd.ie/graysthttp://people.tcd.ie/obyrneke
Description:
PUBLISHED
Author: GRAY, STEVEN; O'BYRNE, KEN
Type of material:
Journal ArticleCollections
Series/Report no:
PloS one8
8
Availability:
Full text availableKeywords:
Apoptosis, Cell cycle and cell division, Gene expression, Long non-coding RNAs, Mesothelioma, Microarrays, Non-coding RNA sequencesDOI:
http://dx.doi.org/10.1371/journal.pone.0070940ISSN:
1932-6203Metadata
Show full item recordLicences: